We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.41%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$18.5B
AUM Growth
+$2.73B
(+17%)
Cap. Flow
+$1.18B
Cap. Flow
% of AUM
6.38%
Top 10 Holdings %
Top 10 Hldgs %
17.08%
Holding
1,449
New
438
Increased
447
Reduced
240
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$224M |
| 2 |
Boeing
BA
|
+$182M |
| 3 |
Bank of America
BAC
|
+$178M |
| 4 |
Citigroup
C
|
+$126M |
| 5 |
JPMorgan Chase
JPM
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$363M |
| 2 |
BP
BP
|
+$245M |
| 3 |
GSK
GSK
|
+$165M |
| 4 |
Nokia
NOK
|
+$142M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.33% |
| 2 | Technology | 18.71% |
| 3 | Healthcare | 16.5% |
| 4 | Communication Services | 12.26% |
| 5 | Industrials | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
McGrath RentCorp
MGRC
$2.92B
| $550K | ﹤0.01% |
+13,828
| New | +$511K |
|
|
AMRI
952
DELISTED
Albany Molecular Research Inc
AMRI
| $549K | ﹤0.01% |
+54,513
| New | +$659K |
|
953
Insperity
NSP
$2.01B
| $544K | ﹤0.01% |
30,118
+25,386
| +536% | +$455K |
|
954
Crown Holdings
CCK
$13.1B
| $543K | ﹤0.01% |
12,193
-88,450
| -88% | -$3.79M |
|
|
AIRM
955
DELISTED
Air Methods Corp
AIRM
| $542K | ﹤0.01% |
+9,285
| New | +$463K |
|
956
eHealth
EHTH
$43.9M
| $541K | ﹤0.01% |
11,633
-4,455
| -28% | -$186K |
|
|
ICON
957
DELISTED
Iconix Brand Group, Inc.
ICON
| $541K | ﹤0.01% |
+1,363
| New | +$502K |
|
958
Ventas
VTR
$47.9B
| $535K | ﹤0.01% |
+8,173
| New | +$568K |
|
|
SVC
959
Service Properties Trust
SVC
$1.07B
| $533K | ﹤0.01% |
+3,969
| New | +$552K |
|
|
QGENF
960
DELISTED
QIAGEN NV
QGENF
| $531K | ﹤0.01% |
+22,313
| New | +$531K |
|
961
InterContinental Hotels
IHG
$23.2B
| $530K | ﹤0.01% |
11,098
-47,851
| -81% | -$2.08M |
|
962
MaxLinear
MXL
$6.8B
| $525K | ﹤0.01% |
50,377
+25,104
| +99% | +$216K |
|
963
Lesaka Technologies
LSAK
$420M
| $523K | ﹤0.01% |
+59,900
| New | +$636K |
|
|
PDS
964
Precision Drilling
PDS
$974M
| $523K | ﹤0.01% |
+2,795
| New | +$549K |
|
|
AVG
965
DELISTED
AVG Technologies N.V.
AVG
| $523K | ﹤0.01% |
+30,371
| New | +$591K |
|
966
Snap-on
SNA
$21.5B
| $517K | ﹤0.01% |
4,718
-7,004
| -60% | -$727K |
|
|
MTEM
967
DELISTED
Molecular Templates, Inc.
MTEM
| $513K | ﹤0.01% |
+666
| New | +$502K |
|
968
Caleres
CAL
$487M
| $511K | ﹤0.01% |
18,155
-28,228
| -61% | -$691K |
|
|
FCH
969
DELISTED
Felcor Lodging Trust
FCH
| $507K | ﹤0.01% |
+62,125
| New | +$430K |
|
970
Worthington Enterprises
WOR
$2.86B
| $505K | ﹤0.01% |
19,472
+12,233
| +169% | +$304K |
|
|
MFRM
971
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $505K | ﹤0.01% |
+11,723
| New | +$419K |
|
972
Texas Roadhouse
TXRH
$13.7B
| $504K | ﹤0.01% |
+18,122
| New | +$493K |
|
973
Motorcar Parts of America
MPAA
$258M
| $501K | ﹤0.01% |
+25,934
| New | +$409K |
|
974
Costamare
CMRE
$1.77B
| $500K | ﹤0.01% |
+27,353
| New | +$486K |
|
975
Wintrust Financial
WTFC
$10.7B
| $499K | ﹤0.01% |
+10,826
| New | +$479K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Arrowstreet Capital held 1,449 positions worth $18.5B, up 17% from $15.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Arrowstreet Capital deployed $1.18B of net new capital in Q4 2013, opening 438 new positions and adding to 447 existing holdings. Its largest new stake was Bank of America: 11,999,441 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 9.3% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was GSK, an estimated $165M trimmed.
- Arrowstreet Capital's largest Q4 2013 buy was Bank of America: 11,999,441 shares worth $187M.
- Arrowstreet Capital added most to Vodafone in Q4 2013, an estimated $224M increase.
- Arrowstreet Capital's biggest Q4 2013 reduction was GSK, cutting an estimated $165M.
- Arrowstreet Capital fully exited Philip Morris in Q4 2013, selling an estimated $363M.
- Arrowstreet Capital's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2013.
- Arrowstreet Capital opened 438 new positions and closed 319 in Q4 2013.
- Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $18.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2013, filed 14 Feb 2014.